COMP <GO>
UTMD vs STIM // 10Y YIELD & FRED MACRO BETA
Utah Medical Products Inc. (NASDAQ) VS. Neuronetics Inc. (NASDAQ) • 15-METRIC TALLY: UTMD 6
— STIM 3
■ METRIC PARITY
LAST: $66.80 (-2.96%) • MKT CAP: $212.7M
macro-sensitivity
—
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UTMD VS. STIM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UTMD | STIM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.10% | 48.50% | +8.60 | UTMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 26.90% | -35.00% | +61.90 | UTMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.73% | -11.25% | +17.98 | UTMD | /fcf-yield <GO> |
| Operating Margin | 29.60% | -21.10% | +50.70 | UTMD | /operating-margins <GO> |
| Net Profit Margin | — | -26.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.80% | 99.20% | -105.00 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.87% | 0.00% | +1.87 | UTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | STIM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.1 | 50.1 | -19.91 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $212.7M | $181.3M | $31.3M | UTMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UTMD REV | STIM REV | UTMD GROSS % | STIM GROSS % | UTMD FCF | STIM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.5M | $149.2M | 57.1% | 48.5% | $14.3M | -$20.4M |
| FY 2024 | $40.9M | $74.9M | 59.0% | 72.3% | $14.6M | -$31.0M |
| FY 2023 | $50.2M | $71.3M | — | — | $22.3M | -$32.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UTMD // BETA —
STIM // BETA —